The traditional gold standard of clinical trials with a randomized, placebo-controlled design involving hundreds of patients ...
MedPage Today on MSN
Strategy Reduces Inappropriate Proton Pump Inhibitor Use
Patient- and physician-facing interventions together doubled the reductions in PPI use ...
A study failed to show significant cognitive benefits with exercise over 2 years, but the rewards are more likely to manifest ...
Surfshark, a leading VPN provider, is revolutionizing the consumer VPN industry with the launch of its own VPN protocol, Dausos. While traditional VPNs consolidate all user traffic through a single ...
Türkiye: A recent randomized controlled study published in Seminars in Oncology Nursing by Gamze Bozkul from the Faculty of ...
A randomized cross-over pilot study in 10 amateur male triathletes found that a beetroot-based multi-ingredient nitrate ...
Warren Buffett's simple "market closure test" reveals why millions of stressed retail investors are doing investing wrong.
Morning Overview on MSN
New pancreatic cancer drug shows survival gains in early results
For the roughly 64,000 Americans diagnosed with pancreatic cancer each year, the prognosis remains grim — though regimens ...
Patients at high risk for pulmonary complications had similar support needs at 90 days with HFNOT or standard oxygen.
When IVUS did not outperform angiography for guiding percutaneous interventions in two trials, the results offered more questions than answers.
Lyell Immunopharma, Inc. (LYEL) 25th Annual Needham Virtual Healthcare Conference April 14, 2026 11:00 AM EDTCompany ParticipantsLynn Seely - ...
After Replimune’s advanced melanoma drug was rejected for a second time, CEO Sushil Patel slammed the FDA for failing to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results